Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.945
-0.015 (-0.51%)
At close: Sep 25, 2026, 4:00 PM EDT
2.990
+0.045 (1.53%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $881.62 million as of September 25, 2026. Its market cap has decreased by -1.34% in one year.
Market Cap
881.62M
Enterprise Value
802.07M
1-Year Change
-1.34%
Ranking
Category
Stock Price
$2.95
ChartMarket Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $881.62M, a decrease of -33.46%. That is a compound annual growth rate of -6.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 881.62M | -18.68% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cullinan Therapeutics | 953.09M |
| Cybin | 921.29M |
| Alumis | 918.99M |
| Jade Biosciences | 917.07M |
| SpyGlass Pharma | 905.44M |
| Rigel Pharmaceuticals | 900.00M |
| SL Science Holding | 895.32M |
| Apnimed | 877.99M |